30 ML acetylcysteine 200 MG/ML Injection [Acetadote] — RxCUI 582119
RxNorm drug concept · Semantic branded drug
RxCUI 582119
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI582119
Official name30 ML acetylcysteine 200 MG/ML Injection [Acetadote]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAcetadote 6 GM per 30 ML Injection; Acetadote 6 GM in 30 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetylcysteine Oral Inhalation: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It helps loosen thick, sticky mucus in your airways. It's used as an add-on treatment for conditions like chronic bronchitis, emphysema, pneumonia, cystic fibrosis and tracheostomy...
- It's usually breathed in as a mist from a nebulizer, often a few times a day. Follow your prescriber's directions exactly. Clean the nebulizer right after each use so it doesn't cl...
- Don't mix it unless your clinician tells you to. Some antibiotics like tetracycline and erythromycin lactobionate don't mix with it, and safety of other combinations hasn't been es...
- Can I mix it with my other nebulizer medicines?
🕸️ Concept Web — How 30 ML acetylcysteine 200 MG/ML Injection [Acetad... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
30 ML acetylcysteine 200 MG/ML Injection [Acetadote]
RxCUI 582119 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Acetylcysteine
197IN
-
Acetylcysteine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Acetadote
404825BN
-
Acetadote
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetylcysteine Injection
1742774SCDF -
Acetylcysteine Injectable Product
1153149SCDG -
Acetylcysteine Injection [Acetadote]
1742776SBDF -
Acetadote Injectable Product
1168410SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Acetylcysteine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
30 ML acetylcysteine 200 MG/ML Injection
465377SCD -
Acetylcysteine 200 MG/ML
340088SCDC -
Acetylcysteine 200 MG/ML [Acetadote]
582117SBDC
-
30 ML acetylcysteine 200 MG/ML Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
30 ML acetylcysteine 200 MG/ML Injection
SCD · 465377 -
Acetylcysteine 200 MG/ML
SCDC · 340088 -
Acetylcysteine Injection
SCDF · 1742774 -
Acetylcysteine Injectable Product
SCDG · 1153149
Brand-Name Concepts
-
Acetylcysteine 200 MG/ML [Acetadote]
SBDC · 582117 -
Acetylcysteine Injection [Acetadote]
SBDF · 1742776 -
Acetadote Injectable Product
SBDG · 1168410 -
Acetadote
BN · 404825
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 582119 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 66220-0207-30 | 4 VIAL in 1 CARTON (66220-207-30) / 30 mL in 1 VIAL | ACETADOTE | Cumberland Pharmaceuticals Inc. | 2004-01-23 |
Observed labelers:
Cumberland Pharmaceuticals Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0132 | Acetylcysteine injection | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.